D. Veber

D. Veber, A. Badger, I. James, 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Normal prions as a new target of cobalamin (vitamin B12) in rat central nervous system

D. Veber, G. Scalabrino, 2013, Clinical chemistry and laboratory medicine.

Cobalamin (vitamin B12) regulation of PrPC, PrPC-mRNA and copper levels in rat central nervous system

D. Veber, G. Tredici, A. Calligaro, 2012, Experimental Neurology.

Cobalamin ( vitamin B 12 ) regulation of PrPC , PrPC-mRNA and copper levels in rat central nervous system

D. Veber, G. Tredici, A. Calligaro, 2012 .

Pharmacology of L-744,453, a novel nonpeptidyl endothelin antagonist.

W. Greenlee, D. Veber, P. Chakravarty, 1996, Life sciences.

Structure and Design of Potent and Selective Cathepsin K Inhibitors

S. Carr, R. DesJarlais, Baoguang Zhao, 1997 .

Structure-activity studies of atrial natriuretic factor

D. Veber, R. Nutt, S. Brady, 1988 .

Benzodioxocin-3-ones and N-acyl-3-amino-3-buten-2-ones: novel classes of cathepsin K cysteine protease inhibitors.

D. Veber, M. Hemling, D. Yamashita, 2004, The journal of peptide research : official journal of the American Peptide Society.

Design and synthesis of diaminopyrrolidinone inhibitors of human osteoclast cathepsin K.

R. DesJarlais, D. Veber, K. Duffy, 1999, Bioorganic & medicinal chemistry letters.

Structure-based design of non-peptide, carbohydrazide-based cathepsin K inhibitors.

R. DesJarlais, D. Veber, D. Tew, 1999, Bioorganic & medicinal chemistry.

Procede d'inhibition de la cathepsine k

Baoguang Zhao, Y. Ru, D. Veber, 1996 .

Controlled synthesis of peptides in aqueous medium. VIII. Preparation and use of novel .alpha.-amino acid N-carboxyanhydrides

D. Veber, V. Garsky, S. Miller, 1971 .

Second-generation benzodiazepine CCK-B antagonists. Development of subnanomolar analogs with selectivity and water solubility.

J. Kemp, D. Veber, M. Bock, 1994, Journal of medicinal chemistry.

A stereocontrolled synthesis of hydroxyethylene dipeptide isosteres using novel, chiral aminoalkyl epoxides and .gamma.-(aminoalkyl)-.gamma.-lactones

B. E. Evans, D. Veber, K. Rittle, 1985 .

A Stereocontrolled Synthesis of Hydroxyethylene Dipeptide Isosteres Using Novel, Chiral Aminoalkyl Epoxides and γ-(Aminoalkyl) γ-Lactones.

B. E. Evans, D. Veber, K. Rittle, 1986 .

Amide and α-keto carbonyl inhibitors of thrombin based on arginine and lysine: Synthesis, stability and biological characterization

D. Veber, R. Nutt, S. Brady, 1995 .

Inhibition of Thrombin by Peptides Containing Lysyl-α-Keto Carbonyl Derivatives

D. Veber, R. Nutt, S. Brady, 1995, Thrombosis and Haemostasis.

1-(1-[4-[(N-acetyl-4-piperidinyl)oxy]-2-methoxybenzoyl]piperidin-4- yl)-4H-3,1-benzoxazin-2(1H)-one (L-371,257): a new, orally bioavailable, non-peptide oxytocin antagonist.

D. Veber, R. Freidinger, D. Reiss, 1995, Journal of medicinal chemistry.

Titanium(III) as a selective reducing agent for nitroarginyl peptides: synthesis of arginine vasotocin

D. Veber, R. Freidinger, R. Hirschmann, 1978 .

Cholecystokinin antagonists. Synthesis of asperlicin analogues with improved potency and water solubility.

B. E. Evans, D. Veber, K. Rittle, 1986, Journal of medicinal chemistry.

Cholecystokinin antagonists. Synthesis and biological evaluation of 4-substituted 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepines.

B. E. Evans, D. Veber, K. Rittle, 1988, Journal of medicinal chemistry.

Bioactive conformation of luteinizing hormone-releasing hormone: evidence from a conformationally constrained analog.

D. Veber, R. Freidinger, R Saperstein, 1980, Science.

4-Aryl-1,2,3-triazole: a novel template for a reversible methionine aminopeptidase 2 inhibitor, optimized to inhibit angiogenesis in vivo.

Guang Yang, Keith W Ward, D. Veber, 2005, Journal of medicinal chemistry.

The design of metabolically-stable peptide analogs

D. Veber, R. Freidinger, 1985, Trends in Neurosciences.

Design of nonpeptidal ligands for a peptide receptor: cholecystokinin antagonists.

B. E. Evans, D. Veber, K. Rittle, 1987, Journal of medicinal chemistry.

NMR and molecular modeling characterization of RGD containing peptides.

D. Veber, P. Anderson, R. Nutt, 2009, International journal of peptide and protein research.

Synthesis and conformational study of a cyclic hexapeptide analog of somatostatin containing dehydrophenylalanine.

D. Veber, R. Nutt, S. Brady, 2009, International journal of peptide and protein research.

Approaches to peptidomimetics which serve as surrogates for the cis amide bond: novel disulfide-constrained bicyclic hexapeptide analogs of somatostatic.

Roger M. Freidinger, Edward J. Brady, D. Veber, 1993 .

Use of N-Fmoc amino acid chlorides and activated 2-(fluorenylmethoxy)-5(4H)-oxazolones in solid-phase peptide synthesis. Efficient syntheses of highly N-alkylated cyclic hexapeptide oxytocin antagonists related to L-365,209

Roger M. Freidinger, Peter D. Williams, D. Veber, 1992 .

Synthesis of peptides in aqueous medium. VI. Synthesis of an unsymmetrical cystine peptide fragment of insulin

D. Veber, R. Hirschmann, R. G. Denkewalter, 1969 .

The controlled synthesis of peptides in aqueous medium. 3. Use of Leuchs' anhydrides in the synthesis of dipeptides. Mechanism and control of side reactions.

D. Veber, H. Joshua, R. Hirschmann, 1967, The Journal of organic chemistry.

Aspartic protease inhibitors: expedient synthesis of 2-substituted statines.

D. Veber, D. Rich, M. Bursavich, 2001, Organic letters.

Cobalamin as a regulator of serum and cerebrospinal fluid levels of normal prions

L. N. Valenti, D. Veber, C. Briani, 2013, Journal of Clinical Neuroscience.

Experimental and clinical evidence of the role of cytokines and growth factors in the pathogenesis of acquired cobalamin-deficient leukoneuropathy

D. Veber, G. Scalabrino, E. Mutti, 2008, Brain Research Reviews.

New Basis of the Neurotrophic Action of Vitamin B12

D. Veber, G. Scalabrino, E. Mutti, 2003, Clinical chemistry and laboratory medicine.

Cobalamin (vitamin B12) positively regulates interleukin-6 levels in rat cerebrospinal fluid

D. Veber, P. Magni, M. Corsi, 2002, Journal of Neuroimmunology.

Peptides and their retro enantiomers are topologically nonidentical

Roger M. Freidinger, D. Veber, R. Freidinger, 1979 .

Studies on the total synthesis of an enzyme. II. Synthesis of a protected tetratetracontapeptide corresponding to the 21-64 sequence of ribonuclease A.

D. Veber, V. Garsky, R. Nutt, 1969, Journal of the American Chemical Society.

A new amine resolution method and its application to 3-aminobenzodiazepines

B. E. Evans, D. Veber, K. Rittle, 1987 .

Design and evaluation of small peptides mapping the exposed surface of IL-8.

C. E. Peishoff, D. Veber, J. White, 2009, International journal of peptide and protein research.

A New Amine Resolution Method and Its Application to 3‐Aminobenzodiazepines.

B. E. Evans, D. Veber, K. Rittle, 1987 .

Azepanone-based inhibitors of human and rat cathepsin K.

Y. Ru, D. Veber, K. Ward, 2001, Journal of medicinal chemistry.

Structure activity relationships of 5-, 6-, and 7-methyl-substituted azepan-3-one cathepsin K inhibitors.

Baoguang Zhao, M. Head, D. Veber, 2006, Journal of medicinal chemistry.

cis,cis,cis-1,2,3,4-TETRACARBOMETHOXYCYCLOBUTANE; STRUCTURE OF β-HEPTACYCLENE

D. Veber, G. Griffin, 1960 .

The synthesis of peptides in aqueous medium. VII. The preparation and use of 2,5-thiazolidinediones in peptide synthesis.

D. Veber, B. Arison, H. Joshua, 1971, The Journal of organic chemistry.

Synthesis of peptides in aqueous medium. V. Preparation and use of 2,5-thiazolidinediones (NTA's). Use of the 13C-H nuclear magnetic resonance signal as internal standard for quantitative studies.

D. Veber, B. Arison, H. Joshua, 1968, Journal of the American Chemical Society.

Potent dual antagonists of endothelin and angiotensin II receptors derived from α-phenoxyphenylacetic acids (Part III)

Kathryn L. Murphy, David L. Williams, Stacey O'Malley, 1995 .

Conformationally constrained tachykinin analogs which are selective ligands for the eledoisin binding site.

D. Veber, R. Freidinger, J. Maguire, 1986, Molecular pharmacology.

Factors that influence oral bioavailability; a cathepsin K inhibitor for human studies.

D. Veber, 2009, Advances in experimental medicine and biology.

Highly potent inhibitors of methionine aminopeptidase-2 based on a 1,2,4-triazole pharmacophore.

Keizo Yamashita, Guang Yang, D. Veber, 2007, Journal of medicinal chemistry.

Synthesis of thyrotropin-releasing hormone analogues with selective central nervous system effects.

D. Veber, R. Nutt, B. Arison, 1981, Journal of medicinal chemistry.

Cyclic ketone inhibitors of the cysteine protease cathepsin K.

Y. Ru, D. Veber, M. Hemling, 2001, Journal of medicinal chemistry.

Orally active, nonpeptide oxytocin antagonists.

B. E. Evans, D. Veber, K. Rittle, 1992, Journal of medicinal chemistry.

Regulation of the ferritin H subunit by vitamin B12 (cobalamin) in rat spinal cord

D. Veber, G. Cairo, P. Santambrogio, 2002, Journal of neuroscience research.

Identification of an orally active, nonpeptidyl oxytocin antagonist.

B. E. Evans, D. Veber, R. Freidinger, 1993, The Journal of pharmacology and experimental therapeutics.

In vitro pharmacological profile of a novel structural class of oxytocin antagonists.

D. Veber, M. Bock, R. Freidinger, 1991, The Journal of pharmacology and experimental therapeutics.

Thyrotropin-releasing hormone receptors in gut tissues resemble pituitary receptors

D. Veber, R. Chang, V. J. Lotti, 1986, Neuroscience Letters.

Characterization of Tachykinin Receptors by Ligand Binding Studies and by Utilization of Conformationally Restricted Tachykinin Analogues

D. Veber, R. Freidinger, B. Williams, 1986 .

The synthesis of peptides in aqueous medium. IV. A novel protecting group for cysteine.

D. Veber, R. Hirschmann, J. Milkowski, 1968, Tetrahedron letters.

Synthesis of alpha-methyl-DLg-glutathione.

D. Veber, R. Hirschmann, K. Pfister, 1967, Journal of Medicinal Chemistry.

The Controlled Synthesis of Peptides in Aqueous Medium. I. The Use of α-Amino Acid N-Carboxyanhydrides

D. Veber, R. Hirschmann, H. Schwam, 1966 .

Increased spinal cord NGF levels in rats with cobalamin (vitamin B12) deficiency

D. Veber, G. Tredici, M. Corsi, 2006, Neuroscience Letters.

Practical synthesis of cyclic peptides, with an example of dependence of cyclization yield upon linear sequence

D. Veber, R. Freidinger, S. Brady, 1979 .

Chemical synthesis of rat atrial natriuretic factor by fragment assembly on a solid support

D. Veber, R. Nutt, S. Brady, 1987 .

Studies on the total synthesis of an enzyme. V. The preparation of enzymatically active material.

D. Veber, R. Nutt, F. W. Holly, 1969, Journal of the American Chemical Society.

Studies on the total synthesis of an enzyme. I. Objective and strategy.

D. Veber, F. W. Holly, R. Hirschmann, 1969, Journal of the American Chemical Society.

Cobalamin and normal prions: a new horizon for cobalamin neurotrophism.

D. Veber, G. Scalabrino, 2013, Biochimie.

Synthesis of nonreducible bicyclic analogs of somatostatin

Ruth F. Nutt, D. Veber, R. Nutt, 1980 .

Protodetachable Arylsilane Polymer Linkages for Use in Solid Phase Organic Synthesis

D. Veber, B. Chenera, J. Finkelstein, 1995 .

The new partnership of genomics and chemistry for accelerated drug development.

D. Veber, M. Gowen, F. Drake, 1997, Current opinion in chemical biology.

Loss of epidermal growth factor regulation by cobalamin in multiple sclerosis

D. Veber, D. Galimberti, D. Scalabrini, 2010, Brain Research.

Are PrPCs involved in some human myelin diseases? Relating experimental studies to human pathology

D. Veber, G. Scalabrino, 2015, Journal of the Neurological Sciences.

Low levels of cobalamin, epidermal growth factor, and normal prions in multiple sclerosis spinal cord

D. Veber, F. Roncaroli, G. Scalabrino, 2015, Neuroscience.

The octapeptide repeat PrPC region and cobalamin‐deficient polyneuropathy of the rat

D. Veber, G. Tredici, A. Calligaro, 2011, Muscle & nerve.

Use of X-Ray Co-Crystal Structures and Molecular Modeling to Design Potent and Selective Non-Peptide Inhibitors of Cathepsin K

Renee L. DesJarlais, Cheryl A. Janson, R. DesJarlais, 1998 .

Solid-phase synthesis of a combinatorial array of 1,3-bis(acylamino)-2-butanones, inhibitors of the cysteine proteases cathepsins K and L.

D. Veber, D. Tew, D. Yamashita, 1999, Journal of combinatorial chemistry.

Design of potent and selective human cathepsin K inhibitors that span the active site.

J G Gleason, S. Carr, R. DesJarlais, 1997, Proceedings of the National Academy of Sciences of the United States of America.

Design of proteolytically-stable, peptidal renin inhibitors and determination of their fate in vivo.

D. Veber, J. Boger, E. Ulm, 1985, Regulatory peptides. Supplement.

Cobalamin (vitamin B12)-deficiency-induced changes in the proteome of rat cerebrospinal fluid.

D. Veber, E. Gianazza, I. Eberini, 2003, The Biochemical journal.

Indirect down‐regulation of nuclear NF‐κB levels by cobalamin in the spinal cord and liver of the rat

D. Veber, G. Tredici, L. Tacchini, 2008, Journal of neuroscience research.

Large-scale synthesis of a cyclic hexapeptide analog of somatostatin

D. Veber, R. Freidinger, W. L. Whitter, 1987 .

Cobalamin-mediated regulation of transcobalamin receptor levels in rat organs.

B. Seetharam, D. Veber, S. Kalra, 2007, Archives of biochemistry and biophysics.

On the low energy solution conformation of somatostatin.

D. Veber, S. Brady, B. Arison, 1981, Biochemical and biophysical research communications.

Decreased GFAP‐mRNA expression in spinal cord of cobalamin‐deficient rats

D. Veber, A. Morabito, V. Magnaghi, 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Use of papain as a model for the structure-based design of cathepsin K inhibitors: crystal structures of two papain-inhibitor complexes demonstrate binding to S'-subsites.

R. DesJarlais, D. Veber, S. Abdel-Meguid, 1999, Journal of medicinal chemistry.

Structure-based design of cathepsin K inhibitors containing a benzyloxy-substituted benzoyl peptidomimetic.

R. DesJarlais, D. Veber, S. Abdel-Meguid, 1998, Journal of medicinal chemistry.

Conformational modifications of cyclic hexapeptide somatostatin analogs.

D. Veber, R. Freidinger, W. Randall, 2009, International journal of peptide and protein research.

Design and discovery in the development of peptide analogs

D. Veber, 1992 .

Cholecystokinin-A receptor ligands based on the kappa-opioid agonist tifluadom.

B. E. Evans, D. Veber, K. Rittle, 1990, Journal of medicinal chemistry.

Synthesis and Resolution of 3-Amino-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-ones.

B. E. Evans, D. Veber, K. Rittle, 1988 .

Development of a potent thrombin receptor ligand.

D. Veber, R. Nutt, M. Tang, 1995, Journal of medicinal chemistry.

Cobalamin deficiency-induced down-regulation of p75-immunoreactive cell levels in rat central nervous system

D. Veber, L. Aloe, L. Tacchini, 2007, Brain Research.

Useful intermediates for synthesis of dicarba analogs of cystine peptides: selectively protected .alpha.-aminosuberic acid and .alpha.,.alpha.'-diaminosuberic acid of defined stereochemistry

D. Veber, R. Nutt, F. W. Holly, 1980 .

Isonicotinyloxycarbonyl, a novel amino protecting group for peptide synthesis.

D. Veber, R. Hirschmann, Y. C. Lee, 1977, The Journal of organic chemistry.

ISONICOTINYLOXYCARBONYL A NOVEL AMINO PROTECTING GROUP FOR PEPTIDE SYNTHESIS

D. Veber, R. Hirschmann, Y. C. Lee, 1978 .

Non-peptide oxytocin antagonists: identification and synthesis of a potent camphor aminosuccinimide

D. Veber, R. Freidinger, D. Hobbs, 1995 .

Conformationally constrained o-tolylpiperazine camphorsulfonamide oxytocin antagonists. Structural modifications that provide high receptor affinity and suggest a bioactive conformation.

D. Veber, R. Freidinger, R. Ball, 1994, Bioorganic & medicinal chemistry.

Highly active cyclic and bicyclic somatostatin analogues of reduced ring size

D. Veber, R. Nutt, S. Brady, 1979, Nature.

Synthesis of a proposed thymic factor.

D. Veber, R. Nutt, F. W. Holly, 1979, Journal of medicinal chemistry.

Bradykinin agonist activity of a novel, potent oxytocin antagonist.

D. Veber, M. Bock, R. Freidinger, 1991, European Journal of Pharmacology.

Novel oxytocin antagonists

B. E. Evans, D. Veber, M. Bock, 1993 .

Potent and selective cyclic hexapeptide oxytocin antagonists

D. Veber, M. Bock, R. M. Dipardo, 1991 .

Potent and Selective Oxytocin Antagonists Obtained by Chemical Modification of a Streptomyces Silvensis Derived Cyclic Hexapeptide and by Total Synthesis

D. Veber, M. Bock, R. M. Dipardo, 1990 .

Cobalamin deficiency-induced changes of epidermal growth factor (EGF)-receptor expression and EGF levels in rat spinal cord

D. Veber, P. P. D. Fiore, S. Pece, 2011, Brain Research.

ANTINOCISPONSIVE EFFECTS OF NEUROTENSIN AND NEUROTENSIN‐RELATED PEPTIDES

D. Veber, B. Clineschmidt, G. Martin, 1982, Annals of the New York Academy of Sciences.

[Genotyping and phylogenetic analysis of HIV-1 isolates circulating in Russia].

D. Veber, E. Kazennova, A. Bobkov, 1997, Voprosy virusologii.

Receptor ligands which bind the oxytocin receptor with selectivity and high affinity. Chemical modification of a Streptomyces silvensis derived cyclic hexapeptide.

D. Veber, M. Bock, R. M. Dipardo, 1990, Journal of medicinal chemistry.

VITAMIN B12 AND NORMAL PRIONS: TWO FIELDS APPARENTLY SO FAR, BUT IN REALITY SO NEAR

D. Veber, G. Scalabrino, 2014 .

Orally active, non-peptide oxytocin antagonists

B. E. Evans, D. Veber, M. Bock, 1994 .

The solution conformation Ac‐Pen‐Arg‐Gly‐Asp‐Cys‐OH, a potent fibrinogen receptor antagonist

D. Veber, R. Nutt, S. Brady, 1993, Biopolymers.

Inferences about the conformation of somatostatin at a biologic receptor based on NMR studies

D. Veber, B. Arison, R. Hirschmann, 1978 .

Azepanone-based inhibitors of human cathepsin L.

Y. Ru, M. Head, D. Veber, 2005, Journal of medicinal chemistry.

Synthesis of new peptides based on models of receptor-bound conformation.

D. Veber, R. Freidinger, W. L. Whitter, 1987, Psychopharmacology series.

Nonreducible cyclic analogues of somatostatin

D. Veber, F. W. Holly, R. Hirschmann, 1976 .